# 04 - Caffeine intoxication

# Caffeine intoxication

Other substances
CHAPTER 12
■
■The potential effects of caffeine on the metabolism of other drugs, as well as the 
potential to induce a caffeine withdrawal syndrome, should always be considered 
before substituting caffeine-­free drinks.
Caffeine intoxication
The DSM-­519 defines caffeine intoxication as the recent consumption of caffeine, 
usually in excess of 250mg, accompanied by five or more of the symptoms in 
Box 12.1.
In caffeine intoxication, these symptoms cause significant distress or impairment in 
social, occupational or other important areas of functioning and are not due to a ­general 
medical condition or better accounted for by another mental disorder (e.g. an anxiety 
disorder).
Caffeine abuse or dependence as a clinical syndrome has been reported3 and caffeine 
use disorder and caffeine withdrawal are both DSM-­5 diagnoses.
Table 12.3  Interactions with caffeine.
Interacting substance
Effect
Comments
CYP1A2 inhibitors:
Oestrogens
Cimetidine
Fluvoxamine (may decrease 
caffeine clearance by 80%)15
Disulfiram
Reduce caffeine clearance
Effects of caffeine may be prolonged or 
increased
Adverse effects may be increased
May precipitate caffeine toxicity
Cigarette smoke*
CYP1A2 inducer – increased 
caffeine metabolism6
Smokers may require higher doses of caffeine 
to gain desired effects6
Lithium
High doses of caffeine may 
reduce lithium levels
Caffeine withdrawal may cause a lithium level 
rise16
MAOIs
May enhance stimulant CNS 
effects
Clozapine
Caffeine may increase clozapine 
plasma concentrations by up to 
60%17
Thought to be via competitive inhibition of 
CYP1A2. Other drugs affected by 
caffeine-­induced inhibition of the enzyme 
include olanzapine, imipramine and 
clomipramine.
SSRIs
Large doses of caffeine may 
increase risk of serotonin 
syndrome18
Benzodiazepines
Caffeine may act as an antagonist
Caffeine reduces the efficacy of 
benzodiazepines8
* Vaping has no effect on CYP1A2 function.
CNS, central nervous system; MAOIs, monoamine oxidase inhibitors.